retatrutide safety clinical trials study is getting attention — but it's still a research-grade, non‑FDA‑ retatrutide clinical trials efficacy safety

Yoon G et al

Given the potential for significant health improvements with semaglutide GLP-1 use, many find the investment worthwhile, as it may help in avoiding more expensive medical treatments in the future

2018;238(2):R109R119119

Improved Patient Outcomes: By leveraging the strengths of multiple medications, combination therapy can improve overall glycemic control, reducing the risk of diabetes-related complications

60 Ongoing Mechanistic Trials of SGLT2 Inhibitors The wealth of ongoing SGLT2 inhibitor mechanistic trials broadly place an emphasis on investigating (1) cardiac, (2) vascular/hemodynamic, and (3) renal mechanisms (Table IA through IP in the online-only Data Supplement)